Mallinckrodt to co market Sumavel Dose Pro for Migraine in US - 08-Jun-2012

Zogenix Inc. have appointed Mallinckrodt to co market Sumavel Dose Pro in the US. The 95-person Zogenix sales force in the US targeting neurologists, headache specialists and other physicians will be joined by a team of Mallinckrodt sales representatives who market pain drugs to primary care doctors.

Related News

Related Neurological Disorders Information

Related Neurological Disorders Drugs

Back to top

Latest News

10 May 2015
24 May 2013
24 May 2013